novanta - NOVT

NOVT

Close Chg Chg %
122.63 0.09 0.07%

Closed Market

122.72

+0.09 (0.07%)

Volume: 172.03K

Last Updated:

Dec 26, 2025, 4:00 PM EDT

Company Overview: novanta - NOVT

NOVT Key Data

Open

$122.63

Day Range

122.10 - 123.08

52 Week Range

98.27 - 156.88

Market Cap

$4.39B

Shares Outstanding

35.78M

Public Float

35.46M

Beta

1.59

Rev. Per Employee

N/A

P/E Ratio

83.84

EPS

$1.47

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

413.63K

 

NOVT Performance

1 Week
 
2.82%
 
1 Month
 
7.97%
 
3 Months
 
21.47%
 
1 Year
 
-20.69%
 
5 Years
 
1.58%
 

NOVT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About novanta - NOVT

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables, surgical displays and operating room integration technologies, optical data collection and machine vision technologies, radio frequency identification technologies, thermal printers, spectrometry technologies, and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.

NOVT At a Glance

Novanta, Inc.
125 Middlesex Turnpike
Bedford, Massachusetts 01730-1409
Phone 1-781-266-5700 Revenue 949.25M
Industry Electronic Equipment/Instruments Net Income 64.09M
Sector Electronic Technology 2024 Sales Growth 7.665%
Fiscal Year-end 12 / 2025 Employees 3,000
View SEC Filings

NOVT Valuation

P/E Current 83.838
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 86.111
Price to Sales Ratio 5.814
Price to Book Ratio 7.363
Price to Cash Flow Ratio 34.82
Enterprise Value to EBITDA 32.669
Enterprise Value to Sales 6.19
Total Debt to Enterprise Value 0.08

NOVT Efficiency

Revenue/Employee 316,415.00
Income Per Employee 21,362.333
Receivables Turnover 6.285
Total Asset Turnover 0.726

NOVT Liquidity

Current Ratio 2.584
Quick Ratio 1.723
Cash Ratio 0.679

NOVT Profitability

Gross Margin 41.811
Operating Margin 13.094
Pretax Margin 8.329
Net Margin 6.751
Return on Assets 4.902
Return on Equity 9.032
Return on Total Capital 5.267
Return on Invested Capital 5.658

NOVT Capital Structure

Total Debt to Total Equity 63.162
Total Debt to Total Capital 38.711
Total Debt to Total Assets 33.921
Long-Term Debt to Equity 61.107
Long-Term Debt to Total Capital 37.451
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Novanta - NOVT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
706.79M 860.90M 881.66M 949.25M
Sales Growth
+19.67% +21.80% +2.41% +7.67%
Cost of Goods Sold (COGS) incl D&A
421.63M 505.70M 499.77M 552.35M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
43.39M 53.16M 46.61M 55.56M
Depreciation
13.53M 13.55M 14.02M 15.00M
Amortization of Intangibles
29.87M 39.61M 32.60M 40.57M
COGS Growth
+17.70% +19.94% -1.17% +10.52%
Gross Income
285.16M 355.21M 381.90M 396.89M
Gross Income Growth
+22.71% +24.56% +7.51% +3.93%
Gross Profit Margin
+40.35% +41.26% +43.32% +41.81%
2021 2022 2023 2024 5-year trend
SG&A Expense
201.68M 244.67M 256.14M 271.46M
Research & Development
72.52M 85.77M 91.68M 95.52M
Other SG&A
129.16M 158.90M 164.46M 175.94M
SGA Growth
+18.04% +21.32% +4.69% +5.98%
Other Operating Expense
1.41M 3.07M 2.44M 1.14M
Unusual Expense
16.72M 6.78M 15.31M 8.81M
EBIT after Unusual Expense
65.35M 100.68M 108.00M 115.48M
Non Operating Income/Expense
(1.79M) 2.10M 1.57M (4.93M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
7.39M 15.62M 25.82M 31.49M
Interest Expense Growth
+12.54% +111.40% +65.33% +21.97%
Gross Interest Expense
7.39M 15.62M 25.82M 31.49M
Interest Capitalized
- - - -
-
Pretax Income
56.17M 87.16M 83.75M 79.07M
Pretax Income Growth
+16.05% +55.16% -3.91% -5.59%
Pretax Margin
+7.95% +10.12% +9.50% +8.33%
Income Tax
5.84M 13.11M 10.87M 14.98M
Income Tax - Current - Domestic
95.00K 65.00K 14.42M 43.00K
Income Tax - Current - Foreign
9.69M 31.70M 11.17M 30.85M
Income Tax - Deferred - Domestic
- - 493.00K (12.22M)
-
Income Tax - Deferred - Foreign
(4.44M) (18.65M) (2.50M) (15.91M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
50.33M 74.05M 72.88M 64.09M
Minority Interest Expense
- - - -
-
Net Income
50.33M 74.05M 72.88M 64.09M
Net Income Growth
+13.05% +47.13% -1.58% -12.06%
Net Margin Growth
+7.12% +8.60% +8.27% +6.75%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
50.33M 74.05M 72.88M 64.09M
Preferred Dividends
- - - -
-
Net Income Available to Common
50.33M 74.05M 72.88M 64.09M
EPS (Basic)
1.4219 2.0771 2.0332 1.7827
EPS (Basic) Growth
+12.24% +46.08% -2.11% -12.32%
Basic Shares Outstanding
35.40M 35.65M 35.84M 35.95M
EPS (Diluted)
1.4066 2.0622 2.0226 1.7741
EPS (Diluted) Growth
+12.65% +46.61% -1.92% -12.29%
Diluted Shares Outstanding
35.78M 35.91M 36.03M 36.12M
EBITDA
125.47M 160.62M 169.92M 179.86M
EBITDA Growth
+28.04% +28.02% +5.79% +5.85%
EBITDA Margin
+17.75% +18.66% +19.27% +18.95%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 141.50
Number of Ratings 3 Current Quarters Estimate 0.89
FY Report Date 12 / 2025 Current Year's Estimate 3.263
Last Quarter’s Earnings 0.87 Median PE on CY Estimate N/A
Year Ago Earnings 3.08 Next Fiscal Year Estimate 3.653
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 2 3 3
Mean Estimate 0.89 0.85 3.26 3.65
High Estimates 0.92 0.88 3.29 3.75
Low Estimate 0.87 0.81 3.25 3.55
Coefficient of Variance 2.97 5.86 0.71 2.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 1
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Novanta - NOVT

Date Name Shares Transaction Value
Feb 27, 2025 John Burke Chief Accounting Officer 7,697 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Charles Guy Jr Ravetto Co-Chief Operating Officer 825 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Charles Guy Jr Ravetto Co-Chief Operating Officer 7,159 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.3 per share 990,089.70
Feb 27, 2025 Charles Guy Jr Ravetto Co-Chief Operating Officer 7,401 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 John Burke Chief Accounting Officer 479 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 John Burke Chief Accounting Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 John Burke Chief Accounting Officer 7,899 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.3 per share 1,092,431.70
Feb 27, 2025 John Burke Chief Accounting Officer 8,039 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 John Burke Chief Accounting Officer 7,560 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.3 per share 1,045,548.00
Feb 27, 2025 Matthijs Glastra Chief Executive Officer; Director 33,434 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Robert John Buckley Chief Financial Officer 5,426 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Robert John Buckley Chief Financial Officer 91,034 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.3 per share 12,590,002.20
Feb 27, 2025 Robert John Buckley Chief Financial Officer 93,657 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Matthijs Glastra Chief Executive Officer; Director 10,852 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 Matthijs Glastra Chief Executive Officer; Director 28,187 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $138.3 per share 3,898,262.10
Feb 21, 2025 John Lesica Co-Chief Operating Officer 4,515 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 John Lesica Co-Chief Operating Officer 4,167 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Novanta in the News